These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6289628)

  • 21. Study of the density of opioid receptors in the male mouse brain at different stages of sexual maturation.
    Gutiérrez M; Menéndez L; Hidalgo A; Baamonde A
    Methods Find Exp Clin Pharmacol; 1999 Sep; 21(7):459-62. PubMed ID: 10544387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific binding for opiate-like drugs in the placenta.
    Valette A; Reme JM; Pontonnier G; Cros J
    Biochem Pharmacol; 1980 Oct; 29(19):2657-61. PubMed ID: 6252905
    [No Abstract]   [Full Text] [Related]  

  • 23. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain.
    Buller KM; Hamlin AS; Osborne PB
    Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Opiate activity of a bone marrow humoral factor which stimulates antibody production].
    Petrov RV; Vartanian ME; Zozulia AA; Patsakova E; Kost NV
    Biull Eksp Biol Med; 1983 May; 95(5):46-8. PubMed ID: 6303475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of binding at the opioid receptor based upon an agonist/antagonist two-state model.
    Cheney BV; Lahti RA; Barsuhn C; Gay DD
    Mol Pharmacol; 1982 Sep; 22(2):349-59. PubMed ID: 6292693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between the endothelium-derived relaxing factor/nitric oxide system and the endogenous opiate system in the modulation of cerebral and spinal vascular CO2 responsiveness.
    Komjáti K; Greenberg JH; Reivich M; Sándor P
    J Cereb Blood Flow Metab; 2001 Aug; 21(8):937-44. PubMed ID: 11487729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors.
    Oktem HA; Apaydin S
    Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of opiate binding to brain membranes by enzymically inactivated peptidases and tryptic fragments from autolysis.
    Abood LG; Knapp RJ; Reynolds DT
    Subst Alcohol Actions Misuse; 1980; 1(1):53-64. PubMed ID: 7034250
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification and localization of opioid receptors in the opossum lower esophageal sphincter.
    Rattan S; Goyal RK
    J Pharmacol Exp Ther; 1983 Feb; 224(2):391-7. PubMed ID: 6296359
    [No Abstract]   [Full Text] [Related]  

  • 30. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
    Geary WA; Wooten GF
    J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solubilization of opiate receptors from human placenta.
    Ahmed MS; Byrne WL; Klee WA
    Placenta Suppl; 1981; 3():115-21. PubMed ID: 6306641
    [No Abstract]   [Full Text] [Related]  

  • 33. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination of three types of opioid binding sites in rat brain in vivo.
    Rosenbaum JS; Holford NH; Richards ML; Aman RA; Sadée W
    Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Opiate receptor(s) of the frog brain: soluble-phase separation of the macromolecular complexes of an agonist and an antagonist].
    Puget A; Meunier JC
    C R Seances Acad Sci III; 1983; 296(10):475-8. PubMed ID: 6307492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.
    Zagon IS; Smith JP; Conter R; McLaughlin PJ
    Int J Mol Med; 2000 Jan; 5(1):77-84. PubMed ID: 10601579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent studies on heterogeneity and isolation of opioid receptors.
    Simon EJ
    NIDA Res Monogr; 1987; 76():35-41. PubMed ID: 2830528
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain.
    Su TP
    J Pharmacol Exp Ther; 1982 Nov; 223(2):284-90. PubMed ID: 6290634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A radioreceptor assay for opiate drugs in human cerebrospinal fluid and plasma.
    Villiger JW; Boas RA; Taylor KM
    Life Sci; 1981 Jul; 29(3):229-33. PubMed ID: 6270490
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preparation of [3H]-labelled N-[1-(beta-hydroxy beta-phenylethyl)-3-methyl-4-piperidyl]-N-phenylpropionamide and studies of its binding with opiate receptors of mouse brain].
    Zhou DH; Ni CH; Wu YZ; Li ZY; Liu JZ; Tang GZ; Zhao XL
    Yao Xue Xue Bao; 1982 Sep; 17(9):658-62. PubMed ID: 6297237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.